论文部分内容阅读
新华网北京2016年1月21日电据了解,原料药一方面使我国企业获得了可观利润,另一方面也留下产能过剩、环保压力等诸多问题。“对此,一部分原料药企业已经先行一步,纷纷优化产业布局和资源配置,由原料药生产到制剂开发战略转型。”近日,中国化学制药协工业协会执行会长潘广成在接受新华网采访时表示,转型已成为原料药行业的一大趋势。
Xinhua BEIJING, January 21, 2016 It is understood that, on the one hand, APIs have made a considerable profit to Chinese enterprises, on the other hand, they have also left many problems such as overcapacity and environmental pressure. “In this regard, part of the raw material medicine companies have taken the first step, have optimized the industrial layout and resource allocation, from the raw material drug production to the formulation development strategy transformation. ” Recently, China Chemical Pharmaceutical Association Industry Association executive Pan Guangcheng in an interview with Xinhuanet Said that the transformation has become a major trend in the pharmaceutical raw materials industry.